A clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore. Lassa fever is a viral haemorrhagic disease that can be fatal and causes permanent hearing loss in up to one-third of those who… Read More
A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults. The interim results of this National Institutes of Health (NIH)-funded trial were presented at the IDWeek2024 conference in Los Angeles. Colourised transmission… Read More
Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people. The antibodies – a human broadly neutralsing antibody and two antibodies isolated from previously vaccinated monkeys – target… Read More
Will you be attending SLAS2024 in Boston? This year the programme will feature a track curated by DDW taking place in the Ignite Theater ‘Innovation & technology: from lab to patient’. Co-sponsored by Integra Biosciences and Hamamatsu Corporation, the Ignite Theater will be… Read More
A research team from Boston University has caused controversy for work involving the creation of a hybrid SARS-CoV-2 virus. Researchers from Boston University’s National Emerging Infectious Diseases Laboratories conducted a study1 to create a chimeric virus which combined the spike protein of the Omicron variant with the… Read More
A vaccine for a range of mosquito-borne viruses has received positive results from a Phase I clinical trial. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) have developed a vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus… Read More
New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19. The researchers found that more than 10% of people… Read More
